Claudia Buettner

Title: Claudia Buettner: Innovator in Antibody Development

Introduction

Claudia Buettner is a prominent inventor based in Schwetzingen, Germany. She has made significant contributions to the field of biotechnology, particularly in the development of antibodies that target specific receptors in the human body. Her work is crucial for advancing medical treatments and improving patient outcomes.

Latest Patents

Claudia holds a patent for an antibody of human origin that specifically binds to the activated state of the platelet integrin receptor GPIIb/IIIa. This invention is directed towards inhibiting platelet aggregation, which is vital for preventing blood clots and related complications. The patent highlights her innovative approach to addressing critical health issues.

Career Highlights

Claudia is currently employed at Affimed Therapeutics, a company known for its focus on developing next-generation immunotherapies. Her role involves leveraging her expertise in antibody development to create effective treatments for various diseases. With her background and skills, she plays a key role in the company's research and development efforts.

Collaborations

Throughout her career, Claudia has collaborated with notable colleagues, including Stefan Knackmuss and Melvyn Little. These partnerships have allowed her to enhance her research and contribute to groundbreaking advancements in the field of biotechnology.

Conclusion

Claudia Buettner is a remarkable inventor whose work in antibody development is paving the way for innovative medical treatments. Her contributions are essential for the future of healthcare and demonstrate the impact of dedicated research in biotechnology.